Gelissen LMY, Toorop AA, Schipper PM, Hoitsma E, et al. Low natalizumab trough concentrations are associated with reduced seroconversion of the John Cunningham virus in natalizumab-treated patients with multiple sclerosis. J Neurol Neurosurg Psychiatry 2025 Mar 25:jnnp-2024-335761.
PMID: 40132877